Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $834M | $865M | $816M | $822M | $836M | $1.68B | $2.80B | $2.02B | $1.34B | $1.05B |
| Revenue growth | — | 3.8% | -5.6% | 0.7% | 1.7% | 100.5% | 67.2% | -28.0% | -33.5% | -21.6% |
| Operating income | $6.18M | $11.7M | -$12.9M | -$15.7M | -$9.16M | $139M | $270M | $113M | -$16.9M | -$84.4M |
| Operating margin | 0.7% | 1.4% | -1.6% | -1.9% | -1.1% | 8.3% | 9.6% | 5.6% | -1.3% | -8.0% |
| Net income | $7.97M | $37.5M | -$17.0M | -$57.7M | -$13.0M | $132M | $186M | $72.6M | -$14.6M | -$94.9M |
| Net margin | 1.0% | 4.3% | -2.1% | -7.0% | -1.5% | 7.9% | 6.6% | 3.6% | -1.1% | -9.0% |
| EPS (diluted) | $0.15 | $1.01 | -$0.48 | -$1.61 | -$0.36 | $3.53 | $4.95 | $2.05 | -$0.44 | -$2.93 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $30.1M | $45.5M | $21.0M | $5.54M | $27.2M | -$85.6M | $134M | $248M | $120M | $48.3M |
| Capital expenditures | $6.52M | $5.11M | $4.60M | $2.94M | $4.62M | $7.17M | $8.79M | $14.0M | $8.71M | $8.16M |
| Free cash flow | $23.6M | $40.4M | $16.4M | $2.60M | $22.6M | -$92.8M | $125M | $235M | $111M | $40.1M |
| Share buybacks | $0.00 | $0.00 | $5.00M | $0.00 | $0.00 | $0.00 | $35.3M | $57.7M | $37.3M | $6.83M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $20.6M | $25.5M | $16.0M | $1.03M | $1.60M | $1.04M | $3.60M | $17.1M | $81.6M | $109M |
| Total assets | $388M | $468M | $427M | $382M | $357M | $733M | $950M | $681M | $589M | $449M |
| Total liabilities | $237M | $230M | $209M | $219M | $202M | $435M | $498M | $213M | $170M | $126M |
| Long-term debt | $84.8M | $92.3M | $77.9M | $71.0M | $55.8M | $182M | $151M | — | — | — |
| Shareholders' equity | $151M | $237M | $218M | $163M | $154M | $294M | $451M | $468M | $419M | $323M |
| Retained earnings | -$104M | -$67.1M | -$84.1M | -$142M | -$155M | -$22.7M | $160M | $233M | $218M | $123M |
| Shares (wtd avg diluted) | 36.2M | 36.2M | 35.7M | 35.8M | 36.1M | 37.4M | 37.5M | 35.5M | 33.4M | 32.4M |
Every figure is extracted from CROSS COUNTRY HEALTHCARE INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.